Martine Bourrié

1.1k total citations
13 papers, 890 citations indexed

About

Martine Bourrié is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Martine Bourrié has authored 13 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 5 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Martine Bourrié's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Martine Bourrié is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Martine Bourrié collaborates with scholars based in France. Martine Bourrié's co-authors include Yves Berger, Viviane Meunier, G Fabre, Xavier Boulenc, Gérard Fabre, F. Guillou, H Joyeux, Isabelle Fabre, Sylvie Klieber and A Zweibaum and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Martine Bourrié

13 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martine Bourrié France	10	514	337	221	97	96	13	890
Viviane Meunier France	8	507 1.0×	396 1.2×	308 1.4×	102 1.1×	115 1.2×	9	1.1k
Xavier Boulenc France	15	336 0.7×	303 0.9×	198 0.9×	94 1.0×	78 0.8×	19	814
S. E. Clarke United Kingdom	12	597 1.2×	317 0.9×	236 1.1×	75 0.8×	118 1.2×	14	961
A. B. Renwick United Kingdom	24	857 1.7×	341 1.0×	347 1.6×	86 0.9×	137 1.4×	34	1.4k
Timothy J. Strelevitz United States	9	402 0.8×	248 0.7×	237 1.1×	85 0.9×	88 0.9×	13	722
Deborah Dunbar United States	18	789 1.5×	510 1.5×	274 1.2×	147 1.5×	145 1.5×	25	1.3k
J H Lin United States	11	439 0.9×	344 1.0×	299 1.4×	103 1.1×	153 1.6×	13	1.1k
Anima Ghosal United States	16	446 0.9×	273 0.8×	224 1.0×	113 1.2×	98 1.0×	28	946
M Veronese Australia	14	788 1.5×	379 1.1×	440 2.0×	99 1.0×	116 1.2×	21	1.2k
Gloria Y. Kwei United States	14	348 0.7×	324 1.0×	339 1.5×	151 1.6×	118 1.2×	28	1.2k

Countries citing papers authored by Martine Bourrié

Since Specialization

Citations

This map shows the geographic impact of Martine Bourrié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Bourrié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Bourrié more than expected).

Fields of papers citing papers by Martine Bourrié

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Bourrié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Bourrié. The network helps show where Martine Bourrié may publish in the future.

Co-authorship network of co-authors of Martine Bourrié

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Bourrié. A scholar is included among the top collaborators of Martine Bourrié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Bourrié. Martine Bourrié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Vassal, T, et al.. (2013). Effect of deuteration on the metabolism and clearance of some pharmacologically active compounds—synthesis and in vitro metabolism of deuterated derivatives of dronedadrone. Journal of Labelled Compounds and Radiopharmaceuticals. 56(9-10). 504–512. 12 indexed citations

Klieber, Sylvie, Viviane Meunier, Olivier Fedeli, et al.. (2009). Contribution of the N‐glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans. The FASEB Journal. 23(S1). 1 indexed citations

Klieber, Sylvie, Viviane Meunier, Olivier Fedeli, et al.. (2008). Contribution of the N-Glucuronidation Pathway to the Overall in Vitro Metabolic Clearance of Midazolam in Humans. Drug Metabolism and Disposition. 36(5). 851–862. 46 indexed citations

Daher, Wassim, Lydie Pélinski, Sylvie Klieber, et al.. (2006). IN VITRO METABOLISM OF FERROQUINE (SSR97193) IN ANIMAL AND HUMAN HEPATIC MODELS AND ANTIMALARIAL ACTIVITY OF MAJOR METABOLITES ON PLASMODIUM FALCIPARUM. Drug Metabolism and Disposition. 34(4). 667–682. 24 indexed citations

Meunier, Viviane, et al.. (2000). Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up. Xenobiotica. 30(6). 589–607. 60 indexed citations

Bourrié, Martine, Viviane Meunier, Yves Berger, & G Fabre. (1999). Role of Cytochrome P-4502C9 in Irbesartan Oxidation by Human Liver Microsomes. Drug Metabolism and Disposition. 27(2). 288–296. 61 indexed citations

Bourrié, Martine, et al.. (1998). Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line. Pharmaceutical Research. 15(5). 726–733. 193 indexed citations

Bourrié, Martine, Viviane Meunier, Yves Berger, & G Fabre. (1996). Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 321–332. 332 indexed citations

Boulenc, Xavier, Monique Rousset, Viviane Meunier, et al.. (1995). Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs. International Journal of Pharmaceutics. 116(2). 147–158. 62 indexed citations

10.

Perrier, Lionel, et al.. (1994). In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions.. Journal of Pharmacology and Experimental Therapeutics. 271(1). 91–99. 34 indexed citations

11.

Fabre, Gérard, et al.. (1992). Δ2-Valproate biotransformation using human liver microsomal fractions. Pharmacy World & Science. 14(3). 146–151. 3 indexed citations

12.

Fabre, G, Bruno Lacarelle, Martine Bourrié, et al.. (1992). Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes.. Drug Metabolism and Disposition. 20(2). 316–321. 5 indexed citations

13.

Boulenc, Xavier, Martine Bourrié, Isabelle Fabre, et al.. (1992). Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 1471–1478. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact